Health communications and consultancy group Cello Health has bolstered its US reach by acquiring critical analysis and biopharmaceutical insight firm Advantage Healthcare.
The deal will add to Cello Health’s growing US presence and Advantage Healthcare will provide support to global client companies, with senior team members bringing marketing and market research expertise.
Stephen Highley, chairman of Cello Health, said: “We are very pleased to welcome Advantage Healthcare to the group.
“They have achieved an excellent reputation for the services they provide, which fits perfectly with our strategy of addressing our clients’ difficult challenges with high-end advisory services.”
New York and New Jersey, US-based Advantage Healthcare was founded in 1994, focussing on commercial assessments, analog intelligence and a specific rapid response service that provides for turnarounds of half or less than typical timelines.
Debbie Glick, president and founder of Advantage Healthcare, said: “Joining Cello Health will provide a win-win combination for our global healthcare clients, offering a broad base of strategic expertise and service in pipeline and marketed products across nearly 100 disease categories.”